Biliary Tract Carcinoma

Oncology
2
Pipeline Programs
2
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Arcus Biosciences
1 program
1
GemcitabinePhase 2
GS
Gilead SciencesFOSTER CITY, CA
1 program
1
GemcitabinePhase 21 trial
Active Trials
NCT06048133Recruiting33Est. Jul 2027

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
Gilead SciencesGemcitabine

Clinical Trials (1)

Total enrollment: 33 patients across 1 trials

Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)

Start: Mar 2024Est. completion: Jul 202733 patients
Phase 2Recruiting

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 33 patients
2 companies competing in this space